SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · IEX Real-Time Price · USD
42.89
+2.79 (6.96%)
Apr 22, 2024, 4:00 PM EDT - Market closed
SpringWorks Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SWTX stock have an average target of 66.6, with a low estimate of 52 and a high estimate of 74. The average target predicts an increase of 55.28% from the current stock price of 42.89.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 6, 2024.
Analyst Ratings
The average analyst rating for SWTX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $73 → $74 | Buy | Maintains | $73 → $74 | +72.53% | Mar 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $73 → $74 | Strong Buy | Maintains | $73 → $74 | +72.53% | Mar 6, 2024 |
| Barclays | Barclays | Buy Maintains $47 → $63 | Buy | Maintains | $47 → $63 | +46.89% | Feb 29, 2024 |
| Wedbush | Wedbush | Buy Maintains $60 → $70 | Buy | Maintains | $60 → $70 | +63.21% | Feb 26, 2024 |
| Barclays | Barclays | Buy Maintains $41 → $47 | Buy | Maintains | $41 → $47 | +9.58% | Jan 25, 2024 |
Financial Forecast
Revenue This Year
89.08M
from 5.45M
Increased by 1,535.47%
Revenue Next Year
261.43M
from 89.08M
Increased by 193.46%
EPS This Year
-4.81
from -5.15
EPS Next Year
-3.57
from -4.81
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 134.1M | 395.2M | 638.7M | 861.2M | 1.8B |
| Avg | 89.1M | 261.4M | 474.5M | 836.6M | 1.7B |
| Low | 53.1M | 186.5M | 296.0M | 803.8M | 1.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2,361.7% | 343.6% | 144.3% | 81.5% | 111.5% |
| Avg | 1,535.5% | 193.5% | 81.5% | 76.3% | 105.5% |
| Low | 875.1% | 109.3% | 13.2% | 69.4% | 97.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -3.20 | -0.49 | 0.75 | 2.55 |
| Avg | -4.81 | -3.57 | -1.38 | 2.48 |
| Low | -5.85 | -4.33 | -2.99 | 2.38 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.